Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).
Hironaka S, Tsubosa Y, Mizusawa J, Kii T, Kato K, Tsushima T, Chin K, Tomori A, Okuno T, Taniki T, Ura T, Matsushita H, Kojima T, Doki Y, Kusaba H, Fujitani K, Taira K, Seki S, Nakamura T, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group.
Hironaka S, et al. Among authors: seki s.
Cancer Sci. 2014 Sep;105(9):1189-95. doi: 10.1111/cas.12486.
Cancer Sci. 2014.
PMID: 25041052
Free PMC article.
Clinical Trial.